Contemporary Mohs surgery applications

  title={Contemporary Mohs surgery applications},
  author={Timothy J Minton},
  journal={Current Opinion in Otolaryngology \& Head and Neck Surgery},
  • T. Minton
  • Published 1 August 2008
  • Medicine
  • Current Opinion in Otolaryngology & Head and Neck Surgery
Purpose of reviewThe incidence of cutaneous malignancies continues to rise and it is likely that the majority of skin cancers referred to otolaryngologists will have characteristics that necessitate a more complex and aggressive approach. Mohs micrographic surgery is a tissue-sparing technique that allows for excision of cancers under complete microscopic control and thus boasts high cure rates. This paper reviews the Mohs technique and discusses the current indications for Mohs surgery in the… 

Simultaneous intraoperative Mohs clearance and reconstruction for advanced cutaneous malignancies.

Well established for accuracy greater than intraoperative frozen section margin analysis, intraoperative Mohs micrographic surgery provides an optimal method of intraoperative margin assessment of cutaneous malignancies.

Who should have Mohs micrographic surgery?

  • W. Perkins
  • Medicine
    Current opinion in otolaryngology & head and neck surgery
  • 2010
The evidence base for the use of Mohs micrographic surgery for a wide range of cutaneous tumours is growing and the technique continues to develop.

Program Profile A Team Approach to Nonmelanotic Skin Cancer Procedures

Robley Rex VAMC embarked on a new team approach for resectable nonmelanotic skin cancer cases that utilize existing resources or excess capacity to achieve comparable, if not superior, outcomes to the usually more costly private sector outsourcing contractual arrangements.

Mohs’ Micrographic Surgery of the Periorbital Area

A multidisciplinary combination of Mohs micrographic surgery, oculoplastic reconstructive surgery, and other medical and surgical specialties provides optimal patient care when treating periorbital cutaneous cancers.

The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans

MMS is more efficacious in the cure rate and recurrence reduction of DFSP and should be advocated for as first line therapy especially in high recurrence prone zones.

Mohs micrographic surgery miscellaneous indications

The evidence for MMS in the management of melanomas and certain uncommon tumors, including dermatofibrosarcoma protuberans, microcystic adnexal carcinomas, Merkel cell carcinoma, sebaceous carcinoma and desmoplastic trichoepithelioma are reviewed.

Association Between Mohs Surgery Wait Times and Surgical Defect Size in Patients With Squamous Cell or Basal Cell Carcinoma of the Skin

No evidence was found that time delays of up to 1 year from biopsy to MMS impact the growth of NMSCA, and linear regression analysis of major diameter change versus time delay to M MS showed no significant increasing trend over time.

National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.

Cost effectiveness of Mohs micrographic surgery for non-melanoma skin cancer: a systematic review protocol

This systematic review will consider studies that evaluate Mohs micrographic surgery as a treatment for non-melanoma skin cancer, including but not limited to mortality, quality of life, quality-adjusted life years, incidence and recurrence of non-Melanomaskin cancer lesions, and frequency of adverse events.



Mohs micrographic surgery for the treatment of primary cutaneous melanoma.

Mohs Surgery for the Treatment of Melanoma in Situ: A Review

Substantial evidence supports the value of complete margin assessment in the treatment of MIS, particularly in the head and neck region, and complete surgical excision with careful margin assessment is required to adequately treat MIS lesions.

Mohs micrographic surgery: a cost analysis.

Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.

The data support the following conclusions: Mohs surgery is the treatment of choice for recurrent BCC; if the patient is not a surgical candidate and the lesion is small, radiation therapy is an alternative that offers a better chance for cure than the other non-Mohs modalities; and curettage and electrodesiccation should not be used to treat recurrent basal cell carcinoma.

Mohs Micrographic Surgery is Accurate 95.1% of the Time for Melanoma In Situ: A Prospective Study of 167 Cases

MMS is a viable option for treatment of MIS that may increase cure rate and reduce the size of the defect especially in cosmetically and functionally sensitive areas.

Microscopically Controlled Excision of Skin Tumors: Chemosurgery (Mohs): Fresh Tissue Technique

A variation of Mohs' technique, that is, microscopically controlled surgical excision is presented. The use of fresh tissue eliminates the need for zinc chloride paste. This substantially decreases

Longitudinal Diminution of Tumor Size for Basal Cell Carcinoma Suggests Shifting Referral Patterns for Mohs Surgery

Findings at this institution suggest that in recent years, referral patterns have shifted toward a preference for Mohs surgery for the treatment of smaller, primary BCCs, which may result in less complex and more successful aesthetic reconstructions.